Head to Head Comparison: Nymox Pharmaceutical


Nymox Pharmaceutical and Neogen are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations. Nymox Pharmaceutical has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500.



from Biotech News